Fibrinolytic Therapy
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4018Copied!
Version20220308Copied!
PublisherYaleDate2022-03-08T01:02:00-05:00Purpose(Clinical Focus: The purpose of this value set is to represent concepts for fibrinolytic therapy used in the treatment of ST-segment elevation myocardial infarction (STEMI).),(Data Element Scope: This value set may use a model element related to Laboratory Test and Measurement.),(Inclusion Criteria: Includes LOINC codes that represent administration and measurement of fibrinolytic therapy for STEMI treatment.),(Exclusion Criteria: No exclusions.)
Expansion
| Code | Display | System |
|---|---|---|
| 21464-3 | http://loinc.org | |
| 43636-0 | http://loinc.org | |
| 5971-7 | http://loinc.org | |
| 5972-5 | http://loinc.org | |
| 5973-3 | http://loinc.org | |
| 5981-6 | http://loinc.org | |
| 5982-4 | http://loinc.org | |
| 5983-2 | http://loinc.org | |
| 5986-5 | http://loinc.org | |
| 5987-3 | http://loinc.org | |
| 5988-1 | http://loinc.org | |
| 5989-9 | http://loinc.org | |
| 5990-7 | http://loinc.org | |
| 88659-8 | http://loinc.org | |
| LP16885-3 | http://loinc.org | |
| LP16889-5 | http://loinc.org | |
| LP16891-1 | http://loinc.org | |
| LP265990-4 | http://loinc.org |
systemhttp://loinc.org
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"system" : "http://loinc.org",
"extension" : [ {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 18
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
} ]
} ]
},
"date" : "2022-03-08T01:02:00-05:00",
"meta" : {
"versionId" : "16",
"lastUpdated" : "2022-03-08T01:01:59.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "Yale",
"jurisdiction" : [ {
"extension" : [ {
"valueString" : "UNKNOWN",
"url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
} ]
} ],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for fibrinolytic therapy used in the treatment of ST-segment elevation myocardial infarction (STEMI).),(Data Element Scope: This value set may use a model element related to Laboratory Test and Measurement.),(Inclusion Criteria: Includes LOINC codes that represent administration and measurement of fibrinolytic therapy for STEMI treatment.),(Exclusion Criteria: No exclusions.)",
"name" : "FibrinolyticTherapy",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://loinc.org",
"code" : "21464-3",
"display" : "Plasminogen activator urokinase type [Presence] in Tissue",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "43636-0",
"display" : "Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5971-7",
"display" : "Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5972-5",
"display" : "Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5973-3",
"display" : "Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5981-6",
"display" : "Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5982-4",
"display" : "Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5983-2",
"display" : "Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5986-5",
"display" : "Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5987-3",
"display" : "Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5988-1",
"display" : "Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5989-9",
"display" : "Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "5990-7",
"display" : "Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "88659-8",
"display" : "Timing of thrombolytic administration in relation to cardiac arrest",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "LP16885-3",
"display" : "Plasminogen activator tissue type Ag",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "LP16889-5",
"display" : "Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "LP16891-1",
"display" : "Plasminogen activator tissue type",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "LP265990-4",
"display" : "Timing of thrombolytic administration in relation to cardiac arrest",
"version" : "2.74"
} ],
"offset" : 0,
"total" : 18,
"identifier" : "urn:uuid:dec73739-5070-4e86-ae6a-36e682361eb6",
"timestamp" : "2023-06-29T17:23:59-04:00",
"parameter" : [ {
"name" : "count",
"valueInteger" : 1000
}, {
"name" : "offset",
"valueInteger" : 0
} ]
},
"title" : "Fibrinolytic Therapy",
"extension" : [ {
"valueString" : "Yale Author",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2022-12-15",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2022-03-08",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "e443d599-93f3-4aac-9b72-1052f2bc9c8d",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4018",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.3157.4018"
} ],
"version" : "20220308"
}| Title | Version | Status | Publisher | Date |
|---|---|---|---|---|
| Fibrinolytic Therapy | 20220308 | retired | Yale | - |
| Fibrinolytic Therapy | 20220308 | active | Yale | - |